Journals / Haseki Tıp Bülteni / 2020 / Cilt: 58 - Sayı: 2

Evaluation of the Proliferation Markers in Interstitial Cystitis/Bladder Pain Syndrome: An Experimental Model

İnterstisyel Sistit/Mesane Ağrısı Sendromu Deneysel Modellerinde Proliferasyon Belirteçlerinin Değerlendirilmesi

Pages
162–168
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a strongcorrelation between these indicators in the urine of animals withIC/BPS created by a 70% alcohol solution (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study was to determine the level of nervegrowth factor (NGF) and epidermal growth factor (EGF) in ananimal model of interstitial cystitis/bladder pain syndrome (IC/BPS) and identify correlations between them.Methods: IC/BPS modeling was performed on white NewZealand female rabbits divided into six groups depending onthe methods of modeling.
📊
Key Findings & Data:The correlationbetween the indicators was calculated by the Pearson correlationcoefficient.Results: An increase in the concentration of NGF and EGF wasdetected in animals of all experimental groups; a significantlyhigh level of these factors in blood and urine was determinedin a toxic model created with the introduction of urine into thesubmucosal layer of the bladder wall.
💡
Conclusion & Impact:There was a strongcorrelation between these indicators in the urine of animals withIC/BPS created by a 70% alcohol solution (p
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study was to determine the level of nervegrowth factor (NGF) and epidermal growth factor (EGF) in ananimal model of interstitial cystitis/bladder pain syndrome (IC/BPS) and identify correlations between them.Methods: IC/BPS modeling was performed on white NewZealand female rabbits divided into six groups depending onthe methods of modeling. Urine and blood levels of NGF andEGF were determined by the ELISA method. The correlationbetween the indicators was calculated by the Pearson correlationcoefficient.Results: An increase in the concentration of NGF and EGF wasdetected in animals of all experimental groups; a significantlyhigh level of these factors in blood and urine was determinedin a toxic model created with the introduction of urine into thesubmucosal layer of the bladder wall. The correlation betweenNGF and EGF tended to increase by 14 days. There was a strongcorrelation between these indicators in the urine of animals withIC/BPS created by a 70% alcohol solution (p

Özet

Amaç: Bu çalışmanın amacı, interstisyel sistit/mesane ağrısı (IC/ BPS) sendromu deneysel modellerine sahip hayvanlarda sinir büyüme faktörü (NGF) ve epidermal büyüme faktörü (EGF) düzeylerini belirlemek ve aralarındaki ilişkileri tespit etmektir. Yöntemler: Modelleme yöntemlerine bağlı olarak altı gruba ayrılan beyaz Yeni Zelanda dişi tavşanlarında IC/BPS modellemesi yapıldı. Sinir büyüme faktörü ve epidermal büyüme faktörü ELISA yöntemi ile kanda ve idrarda belirlendi. Göstergeler arasındaki korelasyon Pearson katsayısı ile hesaplandı. Bulgular: Tüm deney gruplarındaki hayvanlarda sinir büyüme faktörü ve epidermal büyüme faktörü konsantrasyonunda bir artış tespit edildi; Kan ve idrarda bu faktörlerin anlamlı derecede yüksek olduğu, idrarın mesanenin submukoz tabakasına katılmasıyla toksik bir modelde tespit edildi. Sinir büyüme faktörü ve epidermal büyüme faktörü arasındaki korelasyon 14 gün artma eğilimindeydi. Bu göstergeler arasında hayvanların idrarında %70 alkol solüsyonunun oluşturduğu IC/BPS ile güçlü bir korelasyon vardı (p

🔖

Cite This Article

SHOLAN, R. (2022). Evaluation of the Proliferation Markers in Interstitial Cystitis/Bladder Pain Syndrome: An Experimental Model. Haseki Tıp Bülteni, Cilt: 58 - Sayı: 2, 162–168. https://ajindex.com/articles/535142

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Fang Z, Xu K. Interstitial Cystitis/Bladder Pain Syndrome: a Review and an Update. Curr Bladder Dysfunct Rep 2016;11:391
  2. Patnaik SS, Laganà AS, Vitale SG. et al. Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome. Arch Gynecol Obstet 2017;295:1341-59
  3. Vivas O, Kruse M, Hille B. Nerve Growth Factor Sensitizes Adult Sympathetic Neurons to the Proinflammatory Peptide Bradykinin. Journal of Neuroscience 2014;34:11959-71
  4. Hanno PM, Erickson D, Moldwin R, Faraday MM; American Urological Association. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol 2015;193:1545-53
  5. Gupta P, Gaines N, Sirls LT, Peters KM. A multidisciplinary approach to the evaluation and management of interstitial cystitis/bladder pain syndrome: an ideal model of care. Transl Androl Urol 2015;4: 611-9
  6. Mullins C, Bavendam T, Kirkali Z, Kusek JW. Novel research approaches for interstitial cystitis/bladder pain syndrome: thinking beyond the bladder. Transl Androl Urol 2015;4: 524- 33
  7. Lamb LE, Janicki JJ, Bartolone SN, Peters KM, Chancellor MB. Development of an interstitial cystitis risk score for bladder permeability. PLoS ONE 2017;12:e0185686
  8. Birder LA. Pathophysiology of interstitial cystitis. International Journal of Urology 2019; 26:12-5
  9. Jhang J-F, Kuo H-Ch. Pathomechanism of Interstitial Cystitis/ Bladder Pain Syndrome and Mapping the Heterogeneity of Disease. Int Neurourol J 2016; 20(Suppl 2): S95-104
  10. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 8th edition. Washington (DC): National Academies Press (US); 2011. The National Academies Collection: Reports funded by National Institutes of Health. 246 p
  11. Sand PK. Proposed pathogenesis of painful bladder syndrome/ interstitial cystitis. J Reprod Med 2006;51(3 Suppl):234-40
  12. Bayrak O, Seckiner I, Solakhan M, Karakok M, Erturhan SM, Yagci F. Effects of intravesical dexpanthenol use on lipid peroxidation and bladder histology in a chemical cystitis animal model. Urology 2012;79:1023-6
  13. Schrepf A, O’Donnell M, Luo Y, Bradley CS, Kreder K, Lutgendorf S. Inflammation and inflammatory control ininterstitial cystitis/bladder pain syndrome: Associations with painful symptoms. PAIN 2014;155:1755-61
  14. Steers WD, Tuttle JB. Mechanisms of disease: the role of nerve growth factor in the pathophysiolo